GCP
UTMD icon

GSA Capital Partners’s Utah Medical Products UTMD Stock Holding History

GSA Capital Partners’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,607
Closed -$222K – 2098
2024
Q4 		$222K Buy
3,607
+152
+4% +$9.83K 0.02% 1366
2024
Q3 		$231K Buy
+3,455
New +$235K 0.02% 1358
2024
Q2 		– Sell
-3,151
Closed -$224K – 2044
2024
Q1 		$224K Buy
+3,151
New +$236K 0.02% 1359
2016
Q3 		– Sell
-4,100
Closed -$258K – 1983
2016
Q2 		$258K Buy
4,100
+300
+8% +$19.3K 0.01% 1463
2016
Q1 		$238K Buy
+3,800
New +$224K 0.02% 1419

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

GSA Capital Partners's UTMD Position: Q1 2025 in Review

GSA Capital Partners sold out of Utah Medical Products (UTMD) in Q1 2025, closing a stake of 3,607 shares — an estimated $222K sold.

GSA Capital Partners first reported a position in UTMD in Q1 2016 and held it in 5 quarters. The position peaked at $258K in Q2 2016. 109 funds tracked by Wall St. Rank hold UTMD as of Q1 2025.

  • GSA Capital Partners reported no remaining Utah Medical Products position as of Q1 2025 after selling out during the quarter.
  • GSA Capital Partners sold 3,607 Utah Medical Products shares in Q1 2025, an estimated $222K.
  • GSA Capital Partners first reported a position in Utah Medical Products in Q1 2016 and held it in 5 quarters.
  • GSA Capital Partners's Utah Medical Products position peaked at $258K in Q2 2016.
  • 109 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2025.

Based on GSA Capital Partners's 13F filing for Q1 2025, filed 8 May 2025.